Li, Hua
Chen, Jingying
Liu, Zhengxian
Pan, Lujuan
Lan, Xiaoling
Jiang, Lihe
Huang, Fuda
Funding for this research was provided by:
the Opening Fund of Fujian Provincial Key Laboratory of Innovative Drug Target Research (FJ-YW-2022KF07)
Article History
Received: 7 November 2024
Accepted: 9 December 2024
First Online: 18 December 2024
Declarations
:
: The studies involving humans were approved by the Ethics Committee of Affiliated Hospital of Youjiang Medical University for Nationalities. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.
: The authors declare no competing interests.